Lisa M. Giles - Net Worth and Insider Trading
Lisa M. Giles Net Worth
The estimated net worth of Lisa M. Giles is at least $529,673 dollars as of 2024-11-13. Lisa M. Giles is the Director of GenMark Diagnostics Inc and owns about 22,033 shares of GenMark Diagnostics Inc (GNMK) stock worth over $529,673. Details can be seen in Lisa M. Giles's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lisa M. Giles has not made any transactions after 2016-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lisa M. Giles
Lisa M. Giles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lisa M. Giles owns 3 companies in total, including Milestone Pharmaceuticals Inc (MIST) , GenMark Diagnostics Inc (GNMK) , and HCW Biologics Inc (HCWB) .
Click here to see the complete history of Lisa M. Giles’s form 4 insider trades.
Insider Ownership Summary of Lisa M. Giles
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc | 2020-10-01 | director |
| GNMK | GenMark Diagnostics Inc | 2020-05-29 | director |
| HCWB | HCW Biologics Inc | 2021-10-26 | director |
Lisa M. Giles Latest Holdings Summary
Lisa M. Giles currently owns a total of 1 stock. Lisa M. Giles owns 22,033 shares of GenMark Diagnostics Inc (GNMK) as of August 12, 2016, with a value of $529,673.
Latest Holdings of Lisa M. Giles
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GNMK | GenMark Diagnostics Inc | 2016-08-12 | 22,033 | 24.04 | 529,673 |
Holding Weightings of Lisa M. Giles
Lisa M. Giles Form 4 Trading Tracker
According to the SEC Form 4 filings, Lisa M. Giles has made a total of 0 transactions in GenMark Diagnostics Inc (GNMK) over the past 5 years. The most-recent trade in GenMark Diagnostics Inc is the acquisition of 823 shares on August 12, 2016, which cost Lisa M. Giles around $7,736.
Insider Trading History of Lisa M. Giles
- 1
Lisa M. Giles Trading Performance
GuruFocus tracks the stock performance after each of Lisa M. Giles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lisa M. Giles is 15.98%. GuruFocus also compares Lisa M. Giles's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lisa M. Giles within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lisa M. Giles's insider trading performs compared to the benchmark.
Performance of Lisa M. Giles
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.97 | | | | | |
| Relative Return to S&P 500(%) | 0.74 | | | | | |
Lisa M. Giles Ownership Network
Ownership Network List of Lisa M. Giles
Ownership Network Relation of Lisa M. Giles
Lisa M. Giles Owned Company Details
What does Milestone Pharmaceuticals Inc do?
Who are the key executives at Milestone Pharmaceuticals Inc?
Lisa M. Giles is the director of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .
Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Milestone Pharmaceuticals Inc Insider Transactions
Lisa M. Giles Mailing Address
Above is the net worth, insider trading, and ownership report for Lisa M. Giles. You might contact Lisa M. Giles via mailing address: Durata Therapeutics, Inc., 200 South Wacker Drive Suite 2550, Chicago Il 60606.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
